Rajdeep Das, MD, PhD, FIBMS Director of Histocompatibility and Immunogenetics and Immunotherapy Lab University Hospitals Cleveland Medical Center Cleveland, Ohio, United States Over ...
Ashley Krull, Ph.D. Associate Director, Cell Therapy Manufacturing and Engineering James Cancer Hospital Cellular Therapy Laboratory Assistant Professor, Hematology The Ohio State University ...
by Ashley Krull, PhD Associate Director, Cell Therapy Manufacturing and Engineering James Cancer Hospital Cellular Therapy Laboratory Assistant Professor, Hematology The Ohio State University ...
Yossi Schwartz, MD, MPH Senior Member Department of Pathology/Hematopathology and Laboratory Medicine Moffitt Cancer Center Tampa, Florida, USA Wanxing Cui, PhD Director, Cell Therapy Manufacturing ...
Ashley Krull, Ph.D. Associate Director, Cell Therapy Manufacturing and Engineering James Cancer Hospital Cellular Therapy Laboratory Assistant Professor, Hematology The Ohio State University Columbus, ...
Implementation of Expanded Post-Thaw Viability Testing A Clinical Cell Therapy Laboratory Experience by Dr. Elena Maryamchik, MD Director of Cell Therapy Laboratory Memorial Sloan ...
Sarah Love Wittwer, MLS(ASCP)CM Assistant Supervisor, Human Cellular Therapy Laboratory Mayo Clinic, Rochester, MN USA Margaret (Maggie) DiGuardo, MD Pathologist, Transfusion ...
Endotoxin Testing and Validation by Sufira Kiran, DCLS, BS, MLS(ASCP) CM Associate Director, Quality Assurance Uthealth Science Center Houston, TX Bacterial ...
Environmental Monitoring of Cellular Therapy Laboratory Yvette C. Tanhehco PhD, MD, MS Director of Cellular Therapy Laboratory NewYork-Presbyterian Hospital/Columbia University Irving Medical Center ...
LPC Snapshot - October 2022 Thawing Comparison Between Water Bath, Barkey Plasmatherm, and Via Thaw™ with Non-Mobilized Apheresis Products by Cheryl Cox, MT(ASCP), CSSMBB Director, ...
Survey on Post-Thaw Viability Test of Cryopreserved HPC-A Products The ISCT Lab Practices Committee (LPC) is looking for your input! Please take a moment to complete the survey on post-thaw viability ...
LPC Snapshot - August 2022 Potency Testing in Cell and Gene Therapy Products By: Ted Kieffer, MD, MS Clinical Pathologist/Transfusion Medicine Specialist/Clinical Microbiologist Apheresis ...
LPC Snapshot - June 2022 ISCT 2022 Meeting Highlight - Non-Malignant Applications of CAR T By: Medhat Askar, MD, PhD, MSHPE, F(ACHI), FRCPath Transplant Immunology, COVID-19 & Cell Processing ...
LPC Snapshot - April 2022 Exploring Manufacturing Options for Engineered T-cell Therapies By: Hannah W. Song, Ph.D Biologist, Product Development Center for Cellular Engineering, National ...
Cryopreserved hematopoietic stem/progenitor cells stability program-development, current status and recommendations: A brief report from the AABB-ISCT joint working group cellular therapy product stability ...
Are you a technologist new to CGT? Are you an experienced technologist, lab manager, or quality professional looking for additional training in cell product manufacturing? Don't miss our full-day ...
A Snapshot into the ISCT Lab Practices Committee By: Heather Garrity, MHA Stem Cell Transplant Lab Manager Dana Farber Cancer Institute Boston, MA USA Joseph Schwartz, MD, MPH Medical Director ...
ISCT Laboratory Life Line For ISCT Members, the Laboratory Life Line is an interactive resource for the Cell and Gene Therapy community to engage, troubleshoot and collaborate. Managed by the ISCT ...
Vendor Qualification Under FDA Regulations and ICH/ISO Guidelines by: SUFIRA KIRAN, DCLS, BS, MLS(ASCP) CM QUALITY ASSURANCE MANAGER UTHEALTH SCIENCE CENTER HOUSTON, TX All contract ...